DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II) complex
- 53 Downloads
A novel phenolate-bridged binuclear copper(II) complex, [Cu 2 II (L–3H)Cl] (1, where L = 2,6-bis[((2-hydroxybenzyl)(2-pyridylmethyl)amino)methyl]-4-methylphenol), have been synthesized and characterized. The antiproliferative activity of the complex has been tested in vitro against the human cervical cancer cell line HeLa, human non-small-cell lung cancer cell line A-549, the human breast cancer cell line MCF-7, and the human hepatic cell line LO2. The results show the complex has the low micromolar range (9.4–11.2 µM) of IC50 values towards the three cancer cell lines, which is markedly comparable to those of cisplatin. However 1 exhibited 10.6-fold less toxicity than cisplatin toward normal cells LO2, suggesting that complex 1 had high selectivity between tumor cells and normal cells. The interactions with DNA were investigated by UV–Vis absorption, fluorescence, circular dichroism, and gel electrophoresis. The results show that the copper(II) complex could strongly bind to DNA mainly by the groove binding mode and efficiently cleave the pBR322 plasmid DNA into its nicked and linear forms in the presence of excessive ascorbic acid. In addition, the evaluation of the protein binding ability shows that complex 1 could bind to human serum albumin (HSA) with a moderate binding affinity and quench the intrinsic fluorescence of HSA.
KeywordsBinuclear copper(II) complex Antiproliferative activity DNA cleavage DNA binding Human serum albumin
We acknowledge the financial support from the Natural Science Foundation of Hubei Province (No. 2018CFB658) and the Opening Project of Key Laboratory of Optoelectronic Chemical Materials and Devices, Ministry of Education, Jianghan University (No. JDGD-201810).
- Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601Google Scholar
- Biswas N, Khanra S, Sarkar A, Bhattacharjee S, Manda DP, Chaudhuri A, Chakraborty S, Choudhury CR (2017) One new azido bridged dinuclear copper(II) thiosemicarbazide complex: synthesis, DNA/protein binding, molecular docking study and cytotoxicity activity. New J Chem 41:12996–13011CrossRefGoogle Scholar
- Bloomfield VA, Crothers DM, Tinoco I (1974) Physical chemistry of nucleic acids. Harper and Row, New York, p 432Google Scholar
- Johnson JR (1994) CD of nucleic acids. In: Nakanishi K, Berova N, Woody RW (eds) Circular dichroism: principles and applications. VCH, New York, pp 523–540Google Scholar
- Kellett A, O’Connor M, McCann M, Howe O, Casey A, McCarron P, Kavanagh K, McNamara M, Kennedy S, May DD, Skell PS, O’Shea D, Devereux M (2011) Water-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development. Med Chem Commun 2:579–584CrossRefGoogle Scholar
- Malati MA (1999) Experimental inorganic/physical chemistry. Woodhead Publishing, CambridgeGoogle Scholar
- Raja DS, Bhuvanesh NSP, Natarajan K (2012) DNA binding, protein interaction, radical scavenging and cytotoxic activity of 2-oxo-1,2-dihydroquinoquinoline-3-carbaldehyde(2′-hydroxybenzoyl)hydrazone and its Cu(II) complexes: a structure activity relation study. Inorg Chim Acta 385:81–93CrossRefGoogle Scholar
- Tisato F, Marzano C, Porchia M, Pellei M, Santini C (2010) Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 30:708–749Google Scholar